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a b s t r a c t
Aim: The present study examined the effects of glycolaldehyde (GC) on biochemical param-
eters of human neutrophils and whether the antioxidant astaxanthin associated with
vitamin C can modulate these parameters.
Methods: Neutrophils from healthy subjects were treated with GC (1 mM) followed or not by
the antioxidants astaxanthin (2 mM) and vitamin C (100 mM). We examined the phagocytic
capacity, hypochlorous acid, myeloperoxidase (MPO) and glucose-6-phosphate dehydroge-
nase (G6PDH) activities, cytokines and [Ca2+]i. Also, superoxide anion, hydrogen peroxide,
nitric oxide production, antioxidant enzyme activities and glutathione-recycling system
were evaluated.
Results: GC promoted a marked reduction on the phagocytic capacity, maximal G6PDH and
MPO activities, hypochlorous acid production and release of IL-1b, IL-6 and TNF-a cytokines.
Some impairment in the neutrophils biochemical parameters appears to be mediated by
oxidative stress through ROS/RNS production and calcium reduction. Oxidative stress was
evidenced by reduction in the activities of the main antioxidant enzymes, GSH/GSSG ratio
and in the increment of O2
 and H2O2 and NO
.
Conclusions: Treatment of cells with the combination of the antioxidants astaxanthin and
vitamin C was able to restore some neutrophils function mainly by decreasing ROS/RNS
production and improving the redox state. Overall, our findings demonstrate that GC
modulates several neutrophils biochemical parameters in vitro.
# 2012 Elsevier Ireland Ltd. 
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Glycolaldehyde (GC), a highly reactive hydroxyaldehyde, is
produced by sugar fragmentation at the initial stages of
nonenzymatic glycosylation. In diabetes mellitus, hypergly-
cemia promotes an optimal environment to GC formation.
This metabolite, together with other reactive aldehydes such
as glyoxal and methylglyoxal, plays a central role in the
production of advanced glycation end products (AGEs) and is
implicated in diabetic complications [1,2].* Corresponding author at: Av. Regente Feijo´, 1295, 03342000 Sa˜o Paul
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Open access under the Elsevier OA licenseDespite its role as a glycation agent, GC has biological
effects per se. It was demonstrated that it can inhibit tumor
growth in MCF7 cell line through the intracellular genera-
tion of free radicals [2]. Moreover, their role was shown in
the modification of extracellular matrix proteins in vitro,
which results in difficulty in the interaction cell/matrix, an
effect associated with diabetic nephropathy [3]. Other
effects of GC include its reaction with plasma albumin
decreasing the ability of this protein to link with other
substances [4], and glycation of LDL lipoprotein [5].
Both events are involved in the atherosclerosis processo, SP, Brazil. Tel.: +55 11 26726200; fax: +55 11 26726200.
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[6,7].
GC can be formed from aminoacid L-serine by the action of
myeloperoxidase/H2O2/chlorine system in phagocytes such as
neutrophils [8]. In the presence of equimolar quantities of
H2O2 and L-serine, myeloperoxidase used over 80% of the H2O2
in the reaction to generate GC [8]. Since L-serine concentration
in plasma may reach 200 mM, it suggests that GC concentration
in the vicinity of activated neutrophils, which release
myeloperoxidase from their granules, can reach micromolar
levels.
After formation, the fate of GC in the body is not fully
known. However, there are two possibilities: (i) its conversion
to glyoxal [2] and (ii) the generation of AGEs [9,10]. Like other
short-chain hydroxyaldehydes, GC rapidly enolizes forming a,
b-diacetone and glyoxal, with the concomitant production of
superoxide radical [11–13]. Moreover, an in vitro study showed
that the GC can serve as a substrate for the enzyme xanthine
oxidase, a reaction that also promotes the release of
superoxide radical [14]. Some few studies showed the effects
of GC in different cell types. However, to date, this has not
been well studied in neutrophils. These cells have some
features that favor the formation of GC, such as the respiratory
burst which promotes the formation of hydrogen peroxide in
association with the presence of great content of myeloper-
oxidase. Both GC and AGEs may activate different pathways
which generate an increase in reactive species of oxygen and
nitrogen (ROS/RNS) leading to oxidative stress. Therefore, it is
extremely important that cells have defense mechanisms
against these reactive species.
Neutrophils are typically the first leukocytes to migrate into
inflammatory sites, where they accumulate in large numbers,
and unleash a variety of cellular responses against micro-
organisms and foreign particles. Foremost amongst these
responses is the phagocytosis of non-self targets and a
microbicidal response involving the generation of oxygen
derived reactive intermediates and the release of several lytic
enzymes, cytokines, growth factors, cell surface receptors,
adhesion molecules and chemokines [15]. As a result,
neutrophils have been traditionally regarded as an important
first line of defense against pathogens and other immunogenic
material. Given the importance of neutrophils cells in the
body’s defense against infection as well as a variety of
inflammatory, degenerative, and metabolic disorders in
nonimmune tissues, it is important to determine the effect
of GC on the neutrophils function.
Astaxanthin, 3,30-dihydroxy-b,b-carotene-4,40-dione is a
carotenoid ubiquitous in nature, present especially in the
marine environment [16]. As denoted in the literature
astaxanthin may act as a strong antioxidant by donating
electrons and reacting with free radicals to convert them into a
more stable product and terminate free radical chain reaction
in a wide variety of living organisms [17,18]. However, studies
from our group which evaluated the antioxidant effect of
astaxanthin on human and rats leukocytes, have demonstrat-
ed a weak antioxidant action on these cells [19–24] mainly
decreasing superoxide and hydrogen peroxide production.
On the other hand, vitamin C has important modulatory
actions on the immune system. In fact, neutrophils store
ascorbic acid at 10 mM concentration [25]. It seems that thevitamin C pool in the neutrophils is used by the neutrophils to
destroy the engulfed pathogens, and that dietary supplemen-
tation with vitamin C augments innate immunity [25–27].
Thus, association of antioxidants astaxanthin and vitamin C
could be an interesting strategy in an attempt to increase the
antioxidant effects of both compounds because astaxanthin is
mainly found in the hydrophobic membrane portion whereas
vitamin C is a water-soluble antioxidant. This association
could mimic the vitamin C/a-tocopherol recycling system in
oxidative reactions.
The purpose of the present study was to examine the
effects of GC on some biochemical parameters of human
neutrophils in vitro. In addition, we evaluated whether the
mechanism by which GC modulates these parameters of
neutrophils involves ROS/RNS production and calcium release
and if the addition of the antioxidant astaxanthin associated
with vitamin C can modulate this process.
2. Materials and methods
2.1. Reagents
GC, astaxanthin, vitamin C, dehydroethidium, propidium
iodide and most of the other chemicals were purchased from
Sigma–Aldrich Chemical Company (St. Louis, MO, USA),
excepting the RPMI-1640 culture medium, lucigenin and
pluronic acid, and acetoxymethylester (Fura-2AM), which
came from Invitrogen (CA, USA). Common reagents for buffers
(e.g. PBS) and regular laboratory solutions were obtained from
Labsynth (Diadema, SP, Brazil).
2.2. Subjects
The Ethical Committee of the Universidade Cruzeiro do Sul
approved the experimental procedure of this study. Around 30
healthy adult women and men (mean age 23  5.0) were
included in the present study. The subjects recruited did not
present any systemic or topical therapeutic regimen, a
smoking history, alcohol habits, obesity or any other systemic
diseases at least for the last 2 months (based on an anamnesis
protocol).
2.3. Cell isolation and culture condition
Neutrophils were obtained through the collection of human
peripheral blood by venipuncture procedure in vacuum/
siliconized tubes containing 0.1 mM EDTA. Peripheral blood
neutrophils were isolated under sterile conditions by using a
density gradient present in the reagent Histopaque 1077
(Sigma–Aldrich), according to the manufacturer’s instruction.
After isolation, the neutrophils were counted in a Neubauer
chamber using Trypan blue (1%). Neutrophils (1  106/mL)
were cultured in 1 mL of RPMI-1640 medium supplemented
with 10% fetal bovine serum, 20 mM Hepes, 2 mM glutamine,
and antibiotics (streptomycin 100 units/mL and penicillin
200 units/mL).
Despite its importance as an AGE precursor, with GC-
pyridine and Ne-(carboxymethyl) lysine (CML) being the most
prevalent AGEs derived from GC, glycolaldehyde concentrations
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quantified yet. Nonetheless, GC physiological concentration is
estimated to range from 0.1 to 1 mM [28]. Based on this
information as well as on a dose–response curve carried out
in neutrophils to measure cell viability, all evaluations proposed
in the present study were with GC at 1 mM which was
solubilized in phosphate buffer 0.1 M, pH 7.4. Astaxanthin at
2 mM was solubilized in DMSO (1% in the culture medium). At
this concentration of DMSO we did not observe any antioxidant
effect (data not shown). Vitamin C was used at 100 mM
solubilized in Tyrode’s solution (137 mM NaCl, 2.68 mM KCl,
0.49 mM MgCl2, 12 mM NaHCO3, 0.36 mM NaH2PO4, 5.6 mM D-
glucose, and 5 mM acid HEPES, pH 7.4). Based on these different
types of treatment, the following experimental groups were
created: control (without treatment), GC, GAV (GC + astax-
anthin + vitamin C) and AV (astaxanthin + vitamin C). Cells
were cultured at 5% CO2 for 24 h at 37 8C and then were collected,
centrifuged and stored at 80 8C to assay glutathione content.
To measure antioxidant enzyme activity and cytokines release,
cells were cultured for 18 h in the same condition. ROS
production and phagocytic capacity were assayedin neutrophils
after acute treatment of cells.
2.4. Cell membrane integrity
To assess if the concentration of GC selected for the
experiments did not cause toxicity in neutrophils we assayed
cell viability by using flow cytometer. Immediately after being
obtained and at the end of the culture period (24 h), cells
(5  105) were used to test the membrane integrity. This assay
was carried out in a FACScalibur flow cytometer (Becton
Dickinson, Mountain View, CA) using propidium iodide (PI)
(50 mg/mL) dissolved in phosphate buffered saline (0.137 M
NaCl, 2.7 mM KCl, 8.0 mM Na2HPO4, pH 7.4). Fluorescence of PI
was determined in FL2 channel (orange-red fluorescence –
585/42 nm).
2.5. Neutrophils functional parameters
2.5.1. Phagocytic capacity
Neutrophils (5  105 cell/well) were treated and incubated for
60 min at 37 8C in 1 mL RPMI 1640 medium with opsonized
zymosan particles. Zymosan particles (5  106/well) were
opsonized by incubation in the presence of control serum
for 60 min. Afterwards cells were harvested, cytocentrifuged,
stained and counted in an optical microscope. The score of
phagocytosis was expressed by the number of cells that
had one, two, three, four or more phagocyted zymosan
particles [29].
2.5.2. Measurement of hypochlorous acid (HOCl) production
Production of HOCl by neutrophils was evaluated according to
the method described by [30]. Briefly, after treatment
neutrophils (6  105/well) were stimulated with phorbol
myristate acetate (PMA) (60 ng/well) for 60 min. The reaction
was performed in a modified PBS (NaCl 140 mM, KCl 10 mM,
MgCl2 0.5 mM, CaCl2 1 mM, glucose 1 mg/mL and taurine
5 mM), pH 7.4. Reactions were stopped by the addition of
26.8 units/mL of catalase. Cells were then centrifuged, the
supernatant (200 mL) was collected and was added with 50 mLof solution containing 2 mM of 3,30,5,50-tetramethylbenzidine
(TMB), 100 mM sodium iodide, and 10% dimethylformamide in
400 mM acetate buffer. After 5 min, absorbance was recorded
at 650 nm in a microplate reader and a standard curve (1–
40 mM of HOCl) was used to determine the concentration of
hypochlorous acid [31].
2.5.3. Measurement of myeloperoxidase (MPO) activity
The measurement of MPO enzyme activity was performed by
oxidation of luminol in the presence of H2O2 and PMA
according to [32]. Neutrophils (2  106 cells/well) were exposed
for 30 min, at 37 8C with or without 2 mM of astaxanthin,
100 mM of vitamin C and/or 1 mM of GC in the presence or
absence of PMA. Chemiluminescence was determined in a
microplate reader and results are expressed as relative
luminescence unit (RLU).
2.5.4. Glucose-6-phosphate dehydrogenase (G6PDH) activity
The maximum activity of G6PDH enzyme was determined as
Guerra and Otton [24]. The extraction buffer consisted of Tris–
HCl (50 mM), EDTA (1 mM) at pH 8.0. The reaction buffer used
contained Tris–HCl (86 mM), MgCl2 (6.9 mM), NADP + (0.4 mM),
glucose-6-phosphate (1.2 mM) and Triton X-100 0.05% (v/v) at
pH 7.6. The total volume of the well was 374 mL. The reaction
was started by adding glucose-6-phosphate to the medium.
The absorbance at 340 nm was analyzed in a microplate reader
(Tecan, Salzburg, Austria) and the results are expressed as
nmol/min/mg of protein.
2.5.5. Release of pro-inflammatory cytokines
Cytokines IL-6, IL-1b and TNF-a were assayed in cell culture
supernatant with ELISA kits according to the manufacturer’s
instructions (Quantikine, R&D System, Minneapolis, MN,
USA). Neutrophils (1  106/mL) were cultured for 18 h in the
presence of LPS as a stimulus (10 mg/mL). Afterwards, cells
were centrifuged (1000  g, 4 8C, 10 min) and the supernatant
was collected and used for cytokines determination. The lower
limits of detection for the ELISA analyses were as follows:
1.17 pg/mL for IL-6 and 1.95 pg/mL for IL1-b and TNF-a.
2.6. Oxidative parameters
2.6.1. Dihydroethidium assay
Dihydroethidium (DHE) is a fluorescence probe used to
measure the intracellular superoxide anion production. This
essay was made according with Guerra and Otton [24]. As a
negative control, cells were treated either with 10 mM DPI or
5 mM rotenone (a complex 1 – electron transport chain
inhibitor) 30 min prior to treatment. Also, to ensure the
specificity of DHE to superoxide anion, hydrogen peroxide
(50 mM) was added to control-PMA stimulated cells. Results are
expressed as relative fluorescence units (RFU).
2.6.2. Lucigenin
The lucigenin chemiluminescent probe was utilized to
measure the extracellular superoxide anion content mainly
produced through NADPH-oxidase activation. Lucigenin
(5 mM) was added to cells (5  105/well) treated with or
without 1 mM of GC in the presence or absence of 2 mM of
astaxanthin, 100 mM of vitamin C in Tyrode’s buffer
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were carried out in triplicate in the presence and absence of
opsonized zymosan particles (1  106/well) used as a ROS-
inducer. As internal control, 10 mM diphenyleneiodonium
(DPI) a NADPH-oxidase inhibitor or 0.4 mM sodium azide (SA)
a complex III – electron transport chain inhibitor were added
to control cells 20 min prior to lucigenin evaluation. The
results are expressed as chemiluminescence relative units.
The statistical analysis was performed by AUC calculation
(area under the curve).
2.6.3. Hydrogen peroxide production by phenol red assay
Hydrogen peroxide (H2O2) production was measured accord-
ing to [33], based on horseradish peroxidases, which
catalyze the phenol red oxidation by H2O2. The production
of H2O2 was measured in the absence and presence of PMA
(20 ng/well).
2.6.4. ROS production by DCFH-DA assay
The probe DCFH-DA was primarily used as an indicator of the
production of H2O2 [34] but it is also described as being
oxidized by other ROS such as HO, ROO, NO and peroxynitrite
[35]. The cells (5  105/well) were preloaded with DCFH-DA
(5 mM) by incubation in culture medium for 30 min. After the
loading period, cells were treated with or without 2 mM of
astaxanthin, 100 mM of vitamin C and 1 mM of GC in Tyrode’s
buffer for 60 min. The experiments were conducted in the
presence or absence of PMA (20 ng/well). As an internal control
50 mM of H2O2were added to control cells under stimulation to
ensure the specificity of DCFH-DA. The results were expressed
as relative fluorescence units (RFU).
2.6.5. Nitric oxide production (NO.)
NO production was performed according to Ding et al. [36]
through nitrite determination. The spectrophotometric anal-
ysis of the total nitrite content was performed by using the
Griess reagent (1% sulfanilic acid, 0.1% N-1-naphthyl-ethyle-
nediamine dihydrochloride) in supernatants. Neutrophils
(5  105/187 mL) in RPMI 1640 medium were treated with or
without 2 mM of astaxanthin, 100 mM of vitamin C and 1 mM of
GC and stimulated with lipopolysaccharide (LPS) at 10 mg/well
for 4 h. Then, the same volume of Griess (187 mL) was added to
cells and the absorbance was measured in 550 nm. The nitrite
concentration was determined using sodium nitrite as a
standard (0–60 mM).
2.7. Intracellular Ca2+ concentration
Changes in cytosolic Ca2+ levels were monitored by fluores-
cence using the calcium-sensitive probe Fura 2-AM [37].
Neutrophils (1  106/well) were treated with or without 2 mM
of astaxanthin, 100 mM of vitamin C and 1 mM of GC in the
presence of opsonized zymosan particles (1  107/well).
Phagocytosis of zymosan particles was used as a physiological
challenge for intracellular calcium mobilization. Transforma-
tion of the fluorescent signal to [Ca2+] (in nmol Ca2+ per
minute) was performed by calibration with ionomycin
(100 mM, maximum concentration) followed by EGTA addition
(60 mM, minimum concentration) according to the Grynkie-
wicz equation [38].2.8. Antioxidant profile of neutrophils
2.8.1. Antioxidant enzyme activity
The assay to evaluate antioxidant enzyme activities and the
reduced (GSH) and disulfide (GSSG) glutathione content were
performed after 24 h of culture with the treatments. After this
period, cells (5  106) were harvested, centrifuged and to pellet
of cells a specific extraction buffer was added. Cells were then
ruptured by ultrasonication in a Vibra Cell apparatus (CT,
USA), centrifuged for 10 min, 10,000  g at 4 8C and the
supernatant was used for analysis.
Superoxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx) and glutathione reductase (GR) activities
were determined in neutrophils using a microplate reader
(Tecan, Salzburg, Austria). CAT activity was measured as
described by [39] based on the direct decomposition of
hydrogen peroxide (H2O2). SOD activity was measured using
the method described by [40] which involves the reduction of
O2
 radicals by nitroblue tetrazolium (NBT) following a linear
first order kinetic during 3 min. Glutathione peroxidase [41]
and glutathione reductase [42] activities were measured based
on the oxidation of b-NADPH in the presence of tert-butyl
hydroperoxide used as substrate.
2.8.2. GSH and GSSG content
GSH and GSSG content in neutrophils were measured as
described by [43]. The method is based on the reaction
between reduced thiol groups (such as in GSH) with 5,50-
dithiobis-2-nitrobenzoic acid (DTNB) to form 5-thio-2-nitro-
benzoic acid (TNB), which is stoichiometrically detected by
absorbance at 412 nm. Purified GSH and GSSG were used as
standards.
2.9. Protein measurement
The total protein content of cells was measured by the method
of Bradford, using BSA as standard [44].
2.10. Statistical analyses
All data points are the mean values with standard errors of at
least three independent experiments. The data were analyzed
by one-way ANOVA followed by the Tukey’s post-test. The
software employed for statistical analysis was GraphPad
Prism (version4; GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Cell membrane integrity
Toxicity of GC on human neutrophils was tested because we
did not intend to work with an apoptotic/necrotic concentra-
tion of GC and/or astaxanthin and vitamin C. Cell viability was
assessed by using a flow cytometer and propidium iodide as a
probe. After 24 h of culture there was no significant loss of cell
membrane integrity among all groups. These results are
indicative that the concentration of GC and both antioxidants
selected to evaluate biochemical parameters of neutrophils
did not cause cell death (Fig. 1). A dose–response curve with
Fig. 1 – Viability of human neutrophils (5 T 105/well) after
24 h of culture. Cells were treated with GC (1 mM) with or
without the antioxidants astaxanthin (2 mM) and vitamin
C (100 mM) and cultured as previously described.
Afterwards, cells were harvested e then analyzed by flow
cytometry using propidium iodide as a probe. Results are
presented as mean W SEM of 3 experiments performed in
triplicate.
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showed that from 2 mM of GC, there was a significant decrease
in cell viability (data not shown).
3.2. Phagocytic capacity
In order to determine the potential of GC to modulate
phagocytic capacity of human neutrophils we measured the
incorporation of opsonized zymosan particles in cells treated
with GC and the antioxidants (Table 1). There was an increase
of 22% in phagocytic capacity of human neutrophils in the AV
group as compared to the control group, whereas there was a
significant decrease of 31% in the phagocytic capacity of
neutrophils after treatment with GC. When GC-treated cells
were added with antioxidants (GAV group), we observed a
complete restoration of phagocytic capacity with similar
values of the control group.
3.3. Myeloperoxidase (MPO) activity
MPO activity was evaluated in neutrophils after treatment of
cells with hydrogen peroxide and luminol (Table 1). AsTable 1 – Functional parameters of human neutrophils. The re
performed in triplicate.
Control 
Phagocytosis (score of phagocytic capacity) 263  11 
MPO (relative luminescence unit) 10,516  688 
HOCl (mM of HOCl/6  105 cells) 19  1 
G6PDH (nmol/min/mg/protein) 49  6 
IL-6 (pg ml1) 428  71 
IL-1b (pg ml1) 122  12 
TNF-a (pg ml1) 70  7 
a Compared to control group ( p < 0.001).
b Compared to GC group ( p < 0.0001).
c Compared to AV group ( p < 0.001).compared with the control group MPO activity was reduced
by 69%, 97% and 94% in GC, GAV and AV groups, respectively.
3.4. Hypochlorous acid production
Neutrophils were stimulated to produce hypochlorous acid by
the addition of PMA (60 ng/well). Hypochlorous acid concen-
tration was significantly reduced by 84%, 92% and 25% in the
GC, GAV and AV groups, respectively when compared with the
control group (Table 1).
3.5. Glucose-6-phosphate dehydrogenase activity
The maximum G6PDH activity was assessed by the reduction
of the co-factor NADP + to NADPH in human neutrophils
(Table 1). GC promoted a significant reduction of 72% in G6PDH
activity and astaxanthin + vitamin C addition (GAV group) did
not restore G6PDH activity as compared to the control group.
3.6. Cytokines release
TNF-a, IL-1b, and IL-6 play important roles in immune
responses to a variety of inflammatory stimuli. Therefore,
the effects of GC on TNF-a, IL-1b, and IL-6 were evaluated. The
levels of these cytokines in the culture supernatants were
measured using ELISA kits. Neutrophils treated with LPS alone
resulted in significant increase in cytokine production relative
to the basal condition (data not shown). The production of pro-
inflammatory cytokines IL-6, IL-1b and TNF-a by human
neutrophils treated with GC was significantly decreased by
100%, 73% and 83%, respectively as compared with LPS-control
cells. Addition of antioxidants in the GAV group was unable to
restore pro-inflammatory cytokines release although a slight
increase was observed. IL-1b and TNF-a were also reduced in
cells treated with the antioxidants (AV group) by 42% and 89%,
respectively.
3.7. Measurement of superoxide anion production
Superoxide anion production was evaluated in the present
study by using two different probes, DHE and lucigenin. As
assayed by DHE probe, GC-treated cells stimulated with PMA
increased the superoxide anion production by 144% and 35%
as compared with the control and PMA-control groups,sults are presented as mean W SEM of 4 experiments
GC GAV AV
181  8a 248  10b,c 320  11a
3303  336a 373  64a,b 592  103a
3  0a 2  0a 14  1a
14  2a 8  1a,c 42  5
<1.2 pg <1.2 pg 420  43
33  4a 38  1a 71  5a
12  2a 16  1a 8  1a
Fig. 2 – (A) Intracellular superoxide anion production assayed by DHE probe, (B) extracellular superoxide anion production
assayed by lucigenin probe, (C) hydrogen peroxide production assayed by phenol red oxidation, and by using DCFH-DA
probe (D) and NO production assayed by Griess reagent (E). Neutrophils were stimulated as described in Section 2. The
results are presented as mean W SEM of 4 experiments performed in triplicate. (a) compared to stimulated- or non-
stimulated control group ( p < 0.0001); (b) compared to GC-stimulated group ( p < 0.001); (c) compared to AV-stimulated group
( p < 0.001).
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decreased production of superoxide anion by 54% as compared
with the control-stimulated group. Addition of antioxidants to
cells treated with GC (GAV group) promoted a reduction of 19%
in superoxide as compared with the GC group in both
unstimulated and stimulated conditions. Rotenone and DPI
were added to neutrophils under PMA-stimulation, and both
inhibitors significantly reduced superoxide anion production to
control-unstimulated levels (Fig. 2A). We also carried out an
internal control by adding 50 mM of H2O2 to PMA-treated cells
and as expected there was no fluorescence, thus ensuring the
specificity of DHE for superoxide anion (data not shown).
Lucigenin probe (Fig. 2B) was used to measure NADPH-
oxidase activation and then extracellular superoxide anion
production because lucigenin is not permeable to cells. For this
purpose neutrophils were challenged with opsonized zymosan
particles. GC-treatment increased the lucigenin luminescence,while addition of astaxanthin plus vitamin C (GAV group)
halved the superoxide anion production as compared with the
GC and control groups. DPI (10 mM) addition 30 min before the
treatment with zymosan particles promoted a total inhibition in
the lucigenin signal, indicating that superoxide anion produc-
tion via NADPH-oxidase activation was removed. Sodium azide
(SA) did not promote a reduction in lucigenin light emission
indicating the specificity of lucigenin to superoxide produced by
NADPH-oxidase.
3.8. Hydrogen peroxide production
Hydrogen peroxide production was evaluated by the method
of phenol red oxidation (Fig. 2C). When neutrophils were
treated with the antioxidants in the AV and GAV groups there
was a significant reduction in the production of hydrogen
peroxide after PMA-stimulation. In the assay using DCFH-DA
Fig. 3 – Total intracellular calcium [Ca2+]i (nM) mobilization monitored during 20 min. Cells (1 T 106/well) were previously
loaded with 5 mM Fura 2-AM during 1 h and then incubated with GC and/or astaxanthin + vitamin C and stimulated with
opsonized zymosan particles (5 T 106/well). The results are presented as mean W SEM of 4 experiments performed in
triplicate.
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3.4-fold in the production of hydrogen peroxide in cells treated
with GC and stimulated with PMA as compared with control-
stimulated group. In the GAV-stimulated group we observed a
reduction of 60% in the production of hydrogen peroxide when
compared with the GC-group. Antioxidants astaxanthin and
vitamin C also reduced hydrogen peroxide production by 71%
when compared to the control-stimulated group. In non-
stimulated cells GC also increased H2O2 production and the
antioxidants again reduced ROS production. As a positive
control for the DCFH-DA probe we added 50 mM of H2O2 and
our data show that DCFH-DA in fact has a high affinity for
hydrogen peroxide.
3.9. Nitric oxide production
The NO production was evaluated in cells at basal and LPS-
stimulated conditions. After LPS-stimulation there was an
increase in NO production of 39% and 52% in the GC and AV
groups, respectively as compared with the control group,
whereas a reduction of 42% was observed in the GAV-
stimulated group when compared to GC-stimulated group.Table 2 – Antioxidant enzyme activities and glutathione conte
mean W SEM of 4 experiments performed in triplicate.
Control 
Total/SOD (U/mg protein) 18  1 
CAT (mmol/min/mg protein) 41  1 
GPx (mU/mg protein) 5  1 
Gr (mU/mg protein) 31  2 
GSH (mM of GSH/mg of protein) 3  0 
GSSG (mM of GSH/mg of protein) 0  0 
GSH/GSSG (mM of GSH/mg of protein) 6  1 
a Compared to the control group ( p < 0.001).
b Compared to the GC group ( p < 0.0001).
c Compared to the AV group ( p < 0.001).3.10. Intracellular calcium concentration
Intracellular calcium mobilization was monitored for 20 min
by using Fura 2-AM probe in neutrophils challenged with
opsonized zymosan particles (Fig. 3). After zymosan addition,
cells treated with GC presented a reduction of 88% in calcium
mobilization as compared with the control group. Addition of
antioxidants in the GAV group prevented the release of
intracellular calcium to the control level.
3.11. Activity of antioxidant enzymes
The total SOD activity was decreased in the GC, GAV and AV
groups by 23%, 51% and 25%, respectively as compared to
the control group (Table 2). Maximum activity of catalase
(CAT) was reduced in 54%, 42% and 32% in the GC, GAV and
AV groups, respectively compared to control while there
was an increase in GPx activity of 18- and 7-fold in the GC
and GAV groups compared with the control. GC reduced the
GR activity in 36% whereas in the GAV group there was an
increase in GR activity of 126% compared to the control
group (Table 2).nt of human neutrophils. The results are presented as
GC GAV AV
14  1a 9  0a,c 14  1a
19  1a 24  2a 27  1a
88  4a 37  3a,c 3  1
20  4a 70  4a,b 23  3a
4  1 6  0a,b 6  1a
2  0a 2  0a,c 0  0
2  0a 3  0c 13  1a
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The content of GSH was increased after addition of antiox-
idants by 100% and 66% in the GAV and AV groups,
respectively when compared with the control group (Table
2). At the same time GSSG content was increased by 200% after
treatment with GC. GSH/GSSG ratio was decreased in the GC
and GAV groups by 66% and 50%, respectively whereas it was
increased by 116% in cells treated with antioxidants (AV
group).
4. Discussion
The results of this study reveal, for the first time, that GC might
exhibits immunomodulatory properties on human neutro-
phils; these properties appear to be attributable to the
overproduction of ROS/RNS associated with the reduced
intracellular calcium concentration which in turn, inhibit
key functions of the neutrophils. We observed that GC
promoted a marked reduction on the phagocytic capacity,
maximal G6PDH and MPO activities, hypochlorous acid
production and release of pro-inflammatory IL-1b, IL-6 and
TNF-a cytokines. Some impairment in the neutrophils
function appears to be mediated by ROS/RNS induction,
increased oxidative stress and reduced calcium release.
Involvement of the oxidative stress could be evidenced by
reduction in the activities of the main antioxidant enzymes, in
the ratio of GSH/GSSG and in the increment of O2
 and H2O2
and NO production. Antioxidants were evaluated separately
(data not shown). The combination of the antioxidants,
however, showed a more pronounced effect. Treatment of
cells with the combination of the antioxidants astaxanthin
and vitamin C was able to restore only partially the
neutrophils dysfunction mainly by decreasing ROS/RNS
production, by improving the redox state and by restoring
calcium release.
Neutrophils are cells that can generate large amounts of
reactive oxygen/nitrogen species as part of their weapon to kill
invading pathogens. When they phagocytose bacteria or are
exposed to soluble stimuli such as phorbol myristate acetate
(PMA), they undergo an oxidative burst to generate superoxide
(O2
) and hydrogen peroxide (H2O2), and HOCl is produced by
the MPO-catalyzed oxidation of chloride by H2O2 [45].
Therefore, phagocytic capacity, MPO activity and production
of HOCl are important functions of neutrophils, because after
their activation and migration to injured tissue it starts the
engulfing of the foreign particles or pathogens in order to
restore tissue homeostasis. In this work we show that
treatment of neutrophils with GC at 1 mM caused a significant
inhibition in the neutrophils phagocytic capacity, MPO activity
and HOCl production (Table 1) which can be understood as
impairment to the neutrophils function. However, treatment
of cells with the association of dietary antioxidants astax-
anthin and vitamin C was able to totally restore phagocytic
capacity but did not improve HOCl production.
Although a weakness of our work is exactly that we did not
measure the microbicidal activity of neutrophils treated with
the combination of antioxidants, we believe that the reduction
in the exacerbated production of ROS achieved by theantioxidants did not affect the microbicidal function of these
cells. In fact, these results have been previously demonstrated
by our group using astaxanthin alone [21,24,46]. Indeed, we
believe that the deleterious effects caused by the excess of ROS
produced by neutrophils during their activation can be
attenuated by the antioxidants, which induce a better redox
balance favoring all cellular functions which depend on an
adequate amount of ROS. Functional parameters of human
neutrophils such as phagocytosis were accompanied by a
decrease in superoxide anion, hydrogen peroxide and HOCl
production in the presence of antioxidants. This is a
conflicting result at first, since antioxidant while promoting
a significant improvement in the phagocytic capacity, pro-
motes a significant reduction in the production of microbicide
molecules responsible for exterminating foreign microorgan-
isms. However, this result confirms our initial idea that
antioxidants combination can, in fact, reduce the deleterious
effects caused by ROS in lipids and proteins of neutrophils and
in tissues underlying lesion by quenching the exacerbated
production of oxidant species (due to the potent antioxidant
properties) without causing impairment of the neutrophil
ability to phagocytose and kill microorganisms. Studies
performed by Jiang et al. [47] using fluorescein conjugated
to polyacrylamide microspheres showed a extensively chlori-
nation when the beads were ingested by neutrophils, but only
approximately 10% of oxygen consumed by the neutrophils
was accounted for as chlorofluoresceins, which was suggested
to be sufficient to kill bacteria.
It is well known that phagocytosis in neutrophils cells is a
process which involves intracellular calcium mobilization. In
the present study we observed a reduced intracellular calcium
concentration in cells treated with GC. Therefore, we can
assume that a modulatory effect promoted by GC in
neutrophils involves calcium release. Addition of astaxanthin
and vitamin C, in turn, was able to restore calcium release and
the phagocytic capacity of neutrophils.
GC in the presence of non toxic concentrations of H2O2
produces glyoxal, a metabolite that is more reactive than GC
itself, which can react with biomolecules such as DNA, lipids
and proteins, triggering a more powerful cytotoxic effect [48].
There was a reduction in the H2O2 elimination in the cells
treated with GC which could be, at least in part, due to reduced
activity of catalase leading to an accumulation of H2O2 (Table
2). This special condition could lead to an increase in the
glyoxal content with consequent ROS production and
damages in biomolecules. On the other hand, GPx activity,
which is involved in hydroperoxide detoxification, as well as
the content of GSSG was increased in GC-treated cells
accompanied by a decreasing in GR activity. High content of
GSSG and decreased GR activity could be related to the reduced
G6PDH activity observed in this study. This special condition
decreases NADPH availability, an essential co-factor to proper
GR activity.
We need to emphasize that for appropriate function of the
enzyme GPx in detoxifying hydroxyaldehydes such as GC, it
needs glutathione in its reduced form (GSH), which then
passes to its disulfide form (GSSG). The reestablishment of
GSSG to its reduced form GSH is carried out by GR (glutathione
reductase), on a system which is dependent on NADPH as a
co-factor. Thus the GSH/GSSG cycle is critically dependent on
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on our results, we can suggest that there is a pro-oxidative
environment in neutrophils treated with GC. Additionally, this
situation can promote an imbalance in the intracellular redox
state of neutrophils, which in turn could affect their function.
Recently, Lorenzi et al. [28,49], had similar results in heart and
kidneys of rats treated in vivo with GC. SOD, catalase and
glyoxalase activities were significantly decreased due to GC-
treatment. Also, decreased thiol content and increased
lipoperoxidation were observed by the authors after 12 and
24 h injections of GC [28,49].
GSH content was more depleted in hepatocytes treated
with GC than in those treated with glyceraldehydes [50]. These
findings are similar to those in our study in which treatment of
cells with GC promoted an increase in GSSG content and a
reduction in GSH/GSSG ratio (Table 2). Addition of astaxanthin
and vitamin C in the GAV group improved GSH/GSSG ratio and
GSH content, as also observed in our recent work [23]. Thus, we
can suggest that the redox imbalance in neutrophils caused by
GC can be prevented, even partially, by the association of
antioxidants astaxanthin and vitamin C.
GC-treatment of neutrophils also induces the NO production
(Fig. 2E). Nitric oxide (NO), an immunomodulator molecule,
regulates various functions of neutrophils. The role of NO is
involved in chemotaxis, adhesion to endothelium, aggregation,
and in the neutrophils-mediated tissue damage [51,52], proba-
bly by modulating ROS generation in neutrophils [26,53]. In
addition, interaction of NO with O2
 leads to the formation of
cytotoxic species, peroxynitrite (ONOO) and hydroxyl radi-
cals. As superoxide anion production was increased in
neutrophils after GC-treatment (Fig. 2A and B), we can assume
that there is a bias for the formation of peroxynitrite because
both substrates were available in large amounts.
In our work this fact may, at least in part, be responsible for
the reduction in neutrophils function observed after treat-
ment of cells with GC. The increment in peroxynitrite
generation can cause damage in some important cellular
structures of neutrophils, for example those involved in the
phagocytosis process. According to Al-Enezi et al. [2] GC can
lead to increase of the intracellular superoxide anion produc-
tion by different mechanisms: inactivation of the cytosolic Cu/
Zn SOD, direct production of superoxide by GC and its adduct
[54], and direct damage of mitochondria.
Also regarding the increase in NO production observed in
neutrophils treated with astaxanthin and vitamin C, some
important considerations must be taken into account. Poly-
morphonuclear cells (PMNs) store high amounts of L-ascorbic
acid, and activated PMNs recycle ascorbic acid/dehydroascor-
bate (DHA) [55]. The precise reason for storing such high
concentrations of ascorbic acid was not clearly defined. Studies
from Sharma et al. [26,53] and showed that ascorbate increased
the availability of NO from PMNs by stabilizing tetrahydro-
biopterin from NO-synthase. As observed by those authors,
ascorbate-induced NO availability in the PMNs led to enhanced
free radical generation and apoptosis, but phagocytic activity
remained unaffected [53]. As showed in our study, neutrophils
treated with antioxidants astaxanthin and vitamin C (AV group)
also presented an increment in NO production which was
accompanied by a reduction of superoxide anion and hydrogen
peroxide production, as well as an improvement in thephagocytic capacity (Fig. 2 and Table 1). Reduced availability
of superoxide anion, promoted by antioxidants in GAV and AV
groups, might have been responsible for lower levels of
peroxynitrite and then improvement in the neutrophils
function seen in these groups.
It is generally accepted that phagocytic cells such as
neutrophils play roles in body responses that extend well
beyond their capacities to function as phagocytes and cell-
releasing cytotoxic compounds. Various cytokines are among
proteins that are produced by PMNs [56]. Consequently, these
cells have the potential to perform active functions in both
afferent and efferent limbs of the immune response [56]. The
ubiquitously expressed NF-kB transcription factor is widely
recognized as a central regulator of inflammatory and
immune processes. This transcription factor exists as a dimer
whose constituent proteins belong to the NF-kB/Rel family
[57]. Endogenous reactive oxygen intermediates have been
implicated in the regulation of NF-kB activation in several
cellular models [58]. NF-kB is a mammalian transcription
factor that controls a number of genes, including iNOS, TNF-a,
IL-1b, and IL-6 all of which are relevant to immunity and
inflammation; NF-kB is activated by LPS via Toll like receptor 4
(TLR4) in neutrophils [59]. In unstimulated cells, NF-kB dimers
are bound to inhibitory kBs (IkBs), and are consequently
retained within the cytoplasm. However, when the cells are
stimulated with pro-inflammatory stimuli, IkBs are rapidly
phosphorylated and degraded via the action of the IkB kinase
(IKK) complex, and the freed NF-kB is translocated to the
nucleus, wherein it binds to target sites and induces the
transcriptions of pro-inflammatory mediators [60].
Our results showed that GC inhibited the release of pro-
inflammatory proteins TNF-a, IL-1b, and IL-6 after LPS-
stimulation (Table 1). Also, the addition of antioxidants in
the GAV group did not promote the restoration of cytokine
levels. Indeed, in the AV group the levels of IL-1b and TNF-a
were also significantly decreased. Probably the mechanism by
which GC decreased pro-inflammatory interleukins produc-
tion differed from that by which antioxidants did. As
previously described by our group and other authors,
carotenoids including astaxanthin present anti-inflammatory
effects [61]. Kim et al. [62] showed that astaxanthin is a potent
inhibitor of tyrosine kinases, inhibiting the MAPK pathway,
decreasing the phosphorylation of extracellular signal-regu-
lated kinases 1 and 2 (ERK1/2), p38 MAPK and MEK pathway,
downregulating the NF-kB activation and ERK1/2 and pMSK-1
pathway. As cited before NF-kB is activated by phosphoryla-
tion and treatment of cells with astaxanthin and vitamin C
may induce a downregulation in NF-kB phosphorylation, thus
decreasing pro-inflammatory mRNA transcription for inter-
leukins including their release. However, the mechanism
underlying the inhibitory effects of astaxanthin + vitamin C on
pro-inflammatory cytokines release in LPS-stimulated neu-
trophils remains to be clearly elucidated.
In summary, our results show that treatment of neutro-
phils with GC at 1 mM promotes a severe injury in neutrophils
biochemical parameters, which involves oxidative stress with
increased production of reactive oxygen and nitrogen species
together with a reduction of endogenous antioxidant defenses
and calcium release. However, we observed an improvement
in the biochemical parameters of the neutrophils and in the
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antioxidants astaxanthin and vitamin C.
The utilization of dietary antioxidants to prevent or reverse
diabetic complications would seem to be a logical approach,
but in practice it has proved disappointing. Perhaps the
relative lack of efficacy reflects an ineffective therapeutic
strategy, typically utilizing single agents or several agents with
similar pharmacologic profiles. Maybe in a near future the
association of antioxidants astaxanthin and vitamin C may act
as an adjuvant in the therapy for the treatment of a variety of
diseases including diabetes mellitus. The answer to the
question as to whether the in vitro neutrophils protection
achieved by this combination of therapy can be translated to
subjects with type 1 diabetes will have to wait until completion
of the ongoing clinical trial.
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